AnteoTech Ltd – Trademark Portfolio
Entity Type: 99
AnteoTech Ltd owns a portfolio of 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as ANTEOX, EUGENI, and ANTEOLINK. Of these, 3 are registered and 2 are pending. The portfolio spans 5 Nice Classification classes, led by Class 1 (Chemicals) and Class 9 (Computers & Electronics).
Unit 4/26 Brandl St
Eight Mile Plains QLD 4113
Showing of trademarks Trademarks
Trademark Classifications
AnteoTech Ltd's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Legal services; security services for the protection of property and individuals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does AnteoTech Ltd have?
AnteoTech Ltd has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 pending, 1 abandoned.
What trademark classes does AnteoTech Ltd file in?
AnteoTech Ltd files trademarks across 5 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 45 (Legal & Security Services), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are AnteoTech Ltd's most well-known trademarks?
AnteoTech Ltd's registered trademark portfolio includes well-known marks such as ANTEOX, EUGENI, and ANTEOLINK. These are among 3 currently registered trademarks in the portfolio.
What is AnteoTech Ltd's trademark registration success rate?
AnteoTech Ltd has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 2 applications are pending review.